Fecal microbiota transplantation (FMT) has achieved satisfactory results in preventing the
recurrence of Clostridioides difficile infection, but these positive outcomes have only been …

Background Current therapies for recurrent Clostridioides difficile infection do not address
the disrupted microbiome, which supports C. difficile spore germination into toxin-producing …

New targets in inflammatory bowel disease therapy: 2021 : Current Opinion in
Gastroenterology New targets in inflammatory bowel disease therapy: 2021 : Current …

Manipulation of the gut microbiota via fecal microbiota transplantation (FMT) has shown
clinical promise in diseases such as recurrent Clostridioides difficile infection (rCDI) …

Gut microbiota dysbiosis is involved in the development of systemic lupus erythematosus
(SLE). The safety and efficacy of fecal microbiota transplantation (FMT) for the treatment of …

Background The clinical treatment of ulcerative colitis (UC) is limited. A traditional Chinese
medicinal formula, Huangqin decoction (HQD), is chronicled in Shang Han Lun and is …

Indigo and indirubin, the active molecules of traditional Chinese medicine indigo naturalis,
exert therapeutic activity for ulcerative colitis (UC). Indigo and indirubin are isomers and …

Genetically engineered microbes that secrete therapeutics, sense and respond to external
environments, and/or target specific sites in the gut fall under an emergent class of …

Our understanding of the microbiome and its implications for human health and disease
continues to develop. Fecal microbiota transplantation (FMT) is now an established …

Extensive research has elucidated the influence of the gut microbiota on human health and
disease susceptibility and resistance. We review recent clinical and laboratory-based …